Immunotherapy and targeted therapy of advanced non-small cell lung carcinoma: Treatment benefits and cost in an unselected real-life population
Project
|Last update
Project leader
Bettina Kulle Andreassen, The Cancer Registry of Norway, Norwegian Institute of Public Health
Project participants
Helga Helseth Hektoen, The Cancer Registry of Norway, Norwegian Institute of Public Health
Giske Ursin, The Cancer Registry of Norway, Norwegian Institute of Public Health
About the project
Start
01.07.2021
End
31.12.2024
Status
Concluded
Project owner/ Project manager
Norwegian Institute of Public Health